Seres Therapeutics, Inc. MCRB
$5.28
-5.04%
at last close
Financials (TTM)
- Revenue
- $1.88 million
- Net Income
- $-22,463,000
- Net Margin
- -1192.94%
- Return on Equity
- -65.05%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.54
- Price / Sales
- 28.17
Over the trailing twelve months, Seres Therapeutics, Inc. generated revenue of $1.88 million and net income of $-22,463,000, a net margin of -1192.94%.
At the last closing price of $5.28, MCRB trades at 28.17 times sales, with a market capitalization of $53.04 million.
Key Stats
- Last Close
- $5.28
- Market Cap
- $53.04 million
- 52-Week Range
- $4.32 – $29.98
- Average Volume
- 62K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.